Improving diagnosis and treatment of acute childhood leukemia in Uganda: impact of flow cytometry. 2018

Ruth Namazzi, and Amos Gaikwad, and Peter Wasswa, and Michael Cubbage, and Joyce B Kambugu, and Philip Kasirye, and Fadhil Geriga, and Carl Allen, and Joseph Lubega
College of Health Sciences, Makerere University, Kampala, Uganda.

UI MeSH Term Description Entries
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000971 Antineoplastic Combined Chemotherapy Protocols The use of two or more chemicals simultaneously or sequentially in the drug therapy of neoplasms. The drugs need not be in the same dosage form. Anticancer Drug Combinations,Antineoplastic Agents, Combined,Antineoplastic Chemotherapy Protocols,Antineoplastic Drug Combinations,Cancer Chemotherapy Protocols,Chemotherapy Protocols, Antineoplastic,Drug Combinations, Antineoplastic,Antineoplastic Combined Chemotherapy Regimens,Combined Antineoplastic Agents,Agent, Combined Antineoplastic,Agents, Combined Antineoplastic,Anticancer Drug Combination,Antineoplastic Agent, Combined,Antineoplastic Chemotherapy Protocol,Antineoplastic Drug Combination,Cancer Chemotherapy Protocol,Chemotherapy Protocol, Antineoplastic,Chemotherapy Protocol, Cancer,Chemotherapy Protocols, Cancer,Combinations, Antineoplastic Drug,Combined Antineoplastic Agent,Drug Combination, Anticancer,Drug Combination, Antineoplastic,Drug Combinations, Anticancer,Protocol, Antineoplastic Chemotherapy,Protocol, Cancer Chemotherapy,Protocols, Antineoplastic Chemotherapy,Protocols, Cancer Chemotherapy
D014454 Uganda A republic in eastern Africa, south of SUDAN and west of KENYA. Its capital is Kampala. Republic of Uganda
D015470 Leukemia, Myeloid, Acute Clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. Myeloid leukemias develop from changes in cells that normally produce NEUTROPHILS; BASOPHILS; EOSINOPHILS; and MONOCYTES. Leukemia, Myelogenous, Acute,Leukemia, Nonlymphocytic, Acute,Myeloid Leukemia, Acute,Nonlymphocytic Leukemia, Acute,ANLL,Acute Myelogenous Leukemia,Acute Myeloid Leukemia,Acute Myeloid Leukemia with Maturation,Acute Myeloid Leukemia without Maturation,Leukemia, Acute Myelogenous,Leukemia, Acute Myeloid,Leukemia, Myeloblastic, Acute,Leukemia, Myelocytic, Acute,Leukemia, Myeloid, Acute, M1,Leukemia, Myeloid, Acute, M2,Leukemia, Nonlymphoblastic, Acute,Myeloblastic Leukemia, Acute,Myelocytic Leukemia, Acute,Myelogenous Leukemia, Acute,Myeloid Leukemia, Acute, M1,Myeloid Leukemia, Acute, M2,Nonlymphoblastic Leukemia, Acute,Acute Myeloblastic Leukemia,Acute Myeloblastic Leukemias,Acute Myelocytic Leukemia,Acute Myelocytic Leukemias,Acute Myelogenous Leukemias,Acute Myeloid Leukemias,Acute Nonlymphoblastic Leukemia,Acute Nonlymphoblastic Leukemias,Acute Nonlymphocytic Leukemia,Acute Nonlymphocytic Leukemias,Leukemia, Acute Myeloblastic,Leukemia, Acute Myelocytic,Leukemia, Acute Nonlymphoblastic,Leukemia, Acute Nonlymphocytic,Leukemias, Acute Myeloblastic,Leukemias, Acute Myelocytic,Leukemias, Acute Myelogenous,Leukemias, Acute Myeloid,Leukemias, Acute Nonlymphoblastic,Leukemias, Acute Nonlymphocytic,Myeloblastic Leukemias, Acute,Myelocytic Leukemias, Acute,Myelogenous Leukemias, Acute,Myeloid Leukemias, Acute,Nonlymphoblastic Leukemias, Acute,Nonlymphocytic Leukemias, Acute
D016130 Immunophenotyping Process of classifying cells of the immune system based on structural and functional differences. The process is commonly used to analyze and sort T-lymphocytes into subsets based on CD antigens by the technique of flow cytometry. Lymphocyte Immunophenotyping,Lymphocyte Subtyping,Immunologic Subtyping,Immunologic Subtypings,Lymphocyte Phenotyping,Subtyping, Immunologic,Subtypings, Immunologic,Immunophenotyping, Lymphocyte,Immunophenotypings,Immunophenotypings, Lymphocyte,Lymphocyte Immunophenotypings,Lymphocyte Phenotypings,Lymphocyte Subtypings,Phenotyping, Lymphocyte,Phenotypings, Lymphocyte,Subtyping, Lymphocyte,Subtypings, Lymphocyte
D053208 Kaplan-Meier Estimate A nonparametric method of compiling LIFE TABLES or survival tables. It combines calculated probabilities of survival and estimates to allow for observations occurring beyond a measurement threshold, which are assumed to occur randomly. Time intervals are defined as ending each time an event occurs and are therefore unequal. (From Last, A Dictionary of Epidemiology, 1995) Kaplan-Meier Survival Curve,Kaplan-Meier Analysis,Kaplan-Meier Survival Curves,Kaplan-Meier Test,Product-Limit Method,Analysis, Kaplan-Meier,Curve, Kaplan-Meier Survival,Curves, Kaplan-Meier Survival,Estimate, Kaplan-Meier,Kaplan Meier Analysis,Kaplan Meier Survival Curve,Kaplan Meier Survival Curves,Kaplan Meier Test,Method, Product-Limit,Methods, Product-Limit,Product Limit Method,Product-Limit Methods,Survival Curve, Kaplan-Meier,Survival Curves, Kaplan-Meier,Test, Kaplan-Meier

Related Publications

Ruth Namazzi, and Amos Gaikwad, and Peter Wasswa, and Michael Cubbage, and Joyce B Kambugu, and Philip Kasirye, and Fadhil Geriga, and Carl Allen, and Joseph Lubega
January 2010, Asian Pacific journal of cancer prevention : APJCP,
Ruth Namazzi, and Amos Gaikwad, and Peter Wasswa, and Michael Cubbage, and Joyce B Kambugu, and Philip Kasirye, and Fadhil Geriga, and Carl Allen, and Joseph Lubega
March 1988, American journal of clinical pathology,
Ruth Namazzi, and Amos Gaikwad, and Peter Wasswa, and Michael Cubbage, and Joyce B Kambugu, and Philip Kasirye, and Fadhil Geriga, and Carl Allen, and Joseph Lubega
April 2001, Seminars in hematology,
Ruth Namazzi, and Amos Gaikwad, and Peter Wasswa, and Michael Cubbage, and Joyce B Kambugu, and Philip Kasirye, and Fadhil Geriga, and Carl Allen, and Joseph Lubega
January 2011, Indian journal of pathology & microbiology,
Ruth Namazzi, and Amos Gaikwad, and Peter Wasswa, and Michael Cubbage, and Joyce B Kambugu, and Philip Kasirye, and Fadhil Geriga, and Carl Allen, and Joseph Lubega
December 2008, Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion,
Ruth Namazzi, and Amos Gaikwad, and Peter Wasswa, and Michael Cubbage, and Joyce B Kambugu, and Philip Kasirye, and Fadhil Geriga, and Carl Allen, and Joseph Lubega
January 2011, Archives of pathology & laboratory medicine,
Ruth Namazzi, and Amos Gaikwad, and Peter Wasswa, and Michael Cubbage, and Joyce B Kambugu, and Philip Kasirye, and Fadhil Geriga, and Carl Allen, and Joseph Lubega
July 2022, Cytometry. Part B, Clinical cytometry,
Ruth Namazzi, and Amos Gaikwad, and Peter Wasswa, and Michael Cubbage, and Joyce B Kambugu, and Philip Kasirye, and Fadhil Geriga, and Carl Allen, and Joseph Lubega
June 2013, American journal of clinical pathology,
Ruth Namazzi, and Amos Gaikwad, and Peter Wasswa, and Michael Cubbage, and Joyce B Kambugu, and Philip Kasirye, and Fadhil Geriga, and Carl Allen, and Joseph Lubega
May 2004, Haematologica,
Ruth Namazzi, and Amos Gaikwad, and Peter Wasswa, and Michael Cubbage, and Joyce B Kambugu, and Philip Kasirye, and Fadhil Geriga, and Carl Allen, and Joseph Lubega
June 1992, Casopis lekaru ceskych,
Copied contents to your clipboard!